1. Home
  2. Health
  3. Multiple Sclerosis

Informed Consent in Clinical Trials

By Julie Stachowiak, Ph.D., About.com

Updated: April 30, 2007

About.com Health's Disease and Condition content is reviewed by the Medical Review Board

Definition: Before enrolling a person in a clinical trial, researchers must obtain informed consent. In informed consent, the person must understand the purpose of the trial, the potential risks and benefits of the trial and the goals of the research. It should also be clear that a study participant can quit the trial at any time (and for any reason) and is free to ask questions about the research. The informed consent document is a signed, legal document and should be read carefully and fully understood.

In an MS trial, it is important the all participants understand what medications or treatments they may receive. Often participants assume that they will receive the medication being tested, but a group of study participants, called the control group, must receive either standard care or a placebo and study participants will not know which one they are receiving until the trial is over.

Explore Multiple Sclerosis
About.com Special Features

Learn how you can reduce your your numbers with these nutrition and exercise tips. More >

Keep yourself, and your family, happy and healthy this fall with these tips. More >

We comply with the HONcode standard for trustworthy health information: verify here.
  1. Home
  2. Health
  3. Multiple Sclerosis
  4. Glossary
  5. Informed Consent - Informed Consent in MS Clinical Trials

©2009 About.com, a part of The New York Times Company.

All rights reserved.